Company Overview and News
2018-10-13 seekingalpha - 6
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
GLBS PERY PSX LCII ABT CRM SHPG CSCO MS AMC COF-P SMPL ISRG SYF DVMT IDA JNJ HON.WI MSFT HLUKF LEVL FTCH APHQF UTHR MTW ADS FB SCL NFLX AXP SKX SU BAC COF-D COF-C COF-F AAPL CCI ELAN HUBB CE SU EB SURF TRIP PVTL GSK EOG SIX JPM PATK SBUX CNTTF KMRFZ CNC CNK WMT NKE SHAK AMZN HON KMI TWTR HCSG GSK TRMB EAF KMR AA DXC CVB EBAY REGN SLB BAC DFS CRON STBA SC UAL GOOGL LTXB AHBIF PENN SCL SLB QCOM WFCNP XLNX PM PG PNK CPB PYPL VMW WGO TLRY USB GS MYL JEC SWI XYF WEED DXC.WI ECL ABT IBM CWH WFC HON BUD C TPR CMCSA THO COF BSVN LECO CGC SNY VLTHF V SCHW HP T MRK SNE DPZ
Chicago, IL –October 11, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Altria (MO - Free Report) , U.S. Bancorp (USB - Free Report) ,Biogen (BIIB - Free Report) , Ecolab (ECL - Free Report) and HSBC Holdings (HSBC - Free Report) .
STZ.B STZ HCS USB HSB 0005 BIIB HSEA HSEB URBN HSBC ECL HBCYF
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Altria (MO), U.S. Bancorp (USB) and Biogen (BIIB). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
LRCX HD LMT GD SCCO UTX HCS USB HSB 0005 BIIB HSEA HSEB HSBC ECL HBCYF
With a market capitalization of approximately $45.53 billion, Ecolab Inc (ECL - Free Report) is likely to gain from a robust product portfolio and strong performance in the Global Industrial segment. However, intense competition, foreign exchange volatility, higher raw material costs and integration risks are primary headwinds.
MASI VEEV SRDX ECL
Chicago, IL – October 8, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Home Depot (HD - Free Report) , Bristol-Myers (BMY - Free Report) , Costco (COST - Free Report) , Ecolab (ECL - Free Report) and Ameriprise Financial (AMP - Free Report) .
WFCNP HD FRC LGNDZ AMP LGNYZ ECL MO WFC SMPL MCFT WTW OZK LGNZZ LGND NR LGNXZ AZPN BYD
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Home Depot (HD), Bristol-Myers (BMY) and Costco (COST). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
AMP HD LMT RAD UTX MTG ECL
2018-10-02 247wallst - 2
Stocks were taking a breather on Tuesday, but that is after the Canada trade deal sent the Dow Jones industrials up about 190 points and the S&P 500 up over 10 points. While the U.S. indexes are effectively at all-time highs, many investors have seen lower upside from buying on market pullbacks than in prior years. Now the investing community has to consider how to position their investments for the rest of 2018 and into 2019.
GE SQ GEC SQNXF SKX SEAS BSX TSLA TRI GNE MS ECL ETSY
Looking for broad exposure to the Materials - Broad segment of the equity market? You should consider the Fidelity MSCI Materials Index ETF (FMAT - Free Report) , a passively managed exchange traded fund launched on 10/21/2013.
FMAT PX FIDU FSLR ECL DWDP
There’s been a lot of focus on the impact of Hurricane Florence, from the initial drama on the Carolina coasts to sustained rainfall that has swamped communities that are 100 miles or more inland.
GNRC XYL FSLR ECL
Innospec has fallen a bit behind other specialty chemical companies serving the fuel additive, personal care, and energy markets, as investors didn't like the margin pressures they saw in Q2.
BHI CLZNY GEYI ECL IOSP
If you're interested in broad exposure to the Large Cap Blend segment of the US equity market, look no further than the VictoryShares US 500 Enhanced Volatility Wtd ETF (CFO - Free Report) , a passively managed exchange traded fund launched on 07/01/2014.
Launched on 07/01/2014, the VictoryShares US 500 Volatility Wtd ETF (CFA - Free Report) is a passively managed exchange traded fund designed to provide a broad exposure to the Large Cap Blend segment of the US equity market.
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"[email protected],"!O8FH-/#PO3&EN96%R:7IE9" [email protected],S,U M-#8O3R Q,2]%(#(X,[email protected][email protected],B]4(#,S,[email protected]@6R [email protected],30Y73X^#65N M9&]B:@[email protected](" @(" @(" @(" @(" @(" @#0HQ-B P(&]B:@T\/"]$96-O9&50 M87)M7!E+UA2968O5ULQ(#(@,5T^/G-T('$UV4,3(P,,T!*&!B9_C/[email protected]\08 "/Y [email protected] M#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')[email protected]*, T*)25%3T8-"B @(" @ M(" @#0HQ.2 P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22 X,R],96YG [email protected]@-S O4R T.
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to ECL / Ecolab, Inc. on message board site Silicon Investor.
as of ET